BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3301167)

  • 1. Platelet catecholamines and platelet function in normal human subjects.
    Wilson AP; Smith CC; Prichard BN; Betteridge DJ
    Clin Sci (Lond); 1987 Jul; 73(1):99-103. PubMed ID: 3301167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of catecholamines between platelets and plasma in normal human subjects.
    Smith CC; Curtis LD; Delamothe AP; Prichard BN; Betteridge DJ
    Clin Sci (Lond); 1985 Jul; 69(1):1-6. PubMed ID: 4064554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus-induced release of endogenous catecholamines from human washed platelets.
    Smith CC; Wilson AP; Prichard BN; Betteridge DJ
    Clin Sci (Lond); 1986 May; 70(5):495-500. PubMed ID: 3698518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of noradrenaline infusion on platelet catecholamine levels and platelet aggregation.
    Tomlinson B; Smith CC; Ong AC; Graham BR; Betteridge DJ; Prichard BN
    J Hypertens Suppl; 1989 Dec; 7(6):S166-7. PubMed ID: 2632706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and platelet free catecholamine concentrations in patients with familial hypercholesterolaemia.
    Smith CC; Prichard BN; Betteridge DJ
    Clin Sci (Lond); 1992 Jan; 82(1):113-6. PubMed ID: 1310910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM; Forscher CA; Sussman II; Mueller HS
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet alpha 2-adrenoceptor and prostacyclin sensitivity are not altered by cigarette smoking--a study of monozygotic twin pairs discordant for smoking.
    Lassila R
    Thromb Res; 1989 May; 54(4):339-48. PubMed ID: 2474869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
    Kjeldsen SE; Gjesdal K; Leren P; Eide IK
    Thromb Haemost; 1988 Oct; 60(2):251-4. PubMed ID: 3217920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamines and modes of delivery: the relation between catecholamine levels and in-vitro platelet aggregation and adrenoreceptor radioligand binding characteristics.
    Jones CR; McCullouch J; Butters L; Hamilton CA; Rubin PC; Reid JL
    Br J Obstet Gynaecol; 1985 Jun; 92(6):593-9. PubMed ID: 2988601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet noradrenaline release in patients with familial hypercholesterolaemia.
    Smith CC; Wilson AP; Prichard BN; Betteridge DJ
    Eur J Clin Invest; 1989 Jun; 19(3):246-50. PubMed ID: 2509210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on human platelets of catecholamines at levels achieved in the circulation.
    Ardlie NG; McGuiness JA; Garrett JJ
    Atherosclerosis; 1985 Dec; 58(1-3):251-9. PubMed ID: 3004519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin release from human platelets after irreversible aggregation.
    Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G
    Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.